Skip to main content

GSI 255 Pill: gray , capsule/oblong, 15mm

Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide

The pill with imprint GSI 255 (Gray, Capsule/Oblong1) has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg and is used for HIV Infection. It belongs to the drug class antiviral combinations and is not a controlled substance.

Images for GSI 255

Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255
Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg GSI 255

Odefsey

Generic Name
emtricitabine/rilpivirine/tenofovir alafenamide
Imprint
GSI 255
Strength
emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
Color
Gray
Size
15.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, polysorbate 20, croscarmellose sodium, magnesium stearate, water, titanium dioxide, magnesium silicate, ferrosoferric oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
61958-2101 Gilead Sciences, Inc.
54569-6645 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.